These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14691022)

  • 1. Cardiovascular pharmacogenomics.
    Roden DM
    Circulation; 2003 Dec; 108(25):3071-4. PubMed ID: 14691022
    [No Abstract]   [Full Text] [Related]  

  • 2. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
    Amankwa K; Krishnan SC; Tisdale JE
    Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular pharmacogenomics].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of adducin polymorphism.
    Bianchi G; Manunta P; Glorioso N
    J Hypertens; 2009 Jun; 27(6):1325-7; author reply 1327-9. PubMed ID: 19454906
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 12. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
    Levy AP; Blum S
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Torsades de pointes caused by cetirizine overdose].
    Renard S; Ostorero M; Yvorra S; Zerrouk Z; Bargas E; Bertocchio P; Pracchia S; Ebagosti A
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):157-61. PubMed ID: 15787309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibutilide (Corvert): suspected association with torsades de pointes.
    CMAJ; 2004 Oct; 171(8):994. PubMed ID: 15497210
    [No Abstract]   [Full Text] [Related]  

  • 19. Seventy-four defibrillations for sotalol-induced torsades de pointes.
    Sürücü H; Tatli E; Değirmenci A; Gökmen G
    Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
    Ginwalla M; Biblo LA; Paydak H
    WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.